Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
In people with type 2 diabetes, the results were also promising
Key finding: BPC-157 significantly reduced brain edema , improved neurological outcomes, and decreased mortality following traumatic brain injury, revealing potent neuroprotective effects
A systematic review of the association between dementia risk factors and cerebrovascular reactivity
The side effects most frequently reported in the clinical literature and in real-world use are typically mild and dose-related: Injection site reaction: Brief redness, mild soreness, or small bruising at the injection site
Injectable GHK-Cu has demonstrated systemic effects in animal models -- lung fibrosis protection, connective tissue remodeling, neuroprotection -- but translating those findings to human subcutaneous injection protocols remains speculative
If you are having trouble ceasing use, you should be honest with your doctor
